Literature DB >> 11141188

Evidence for positive selection in the capsid protein-coding region of the foot-and-mouth disease virus (FMDV) subjected to experimental passage regimens.

M A Fares1, A Moya, C Escarmís, E Baranowski, E Domingo, E Barrio.   

Abstract

We present sequence data from two genomic regions of foot-and-mouth disease virus (FMDV) subjected to several experimental passage regimens. Maximum-likelihood estimates of the nonsynonymous-to-synonymous rate ratio parameter (d(N)/d(S)) suggested the action of positive selection on some antigenic sites of the FMDV capsid during some experimental passages. These antigenic sites showed an accumulation of convergent amino acid replacements during massive serial cytolytic passages and also in persistent infections of FMDV in cell culture. This accumulation was most significant at the antigenic site A (the G-H loop of capsid VP1), which includes an Arg-Gly-Asp (RGD) cellular recognition motif. Our analyses also identified a subregion of VP3, part of the fivefold axis of FMDV particles, that also appeared to be subjected to positive selection of amino acid replacements. From these results, we can conclude that under the restrictive conditions imposed either by the presence of the monoclonal antibodies, by the persistent infections, or by the competition processes established between different variants of the viral population, amino acid replacement in some capsid-coding regions can be positively selected toward an increase of those mutants with a higher capability to infect the cell.

Entities:  

Mesh:

Year:  2001        PMID: 11141188     DOI: 10.1093/oxfordjournals.molbev.a003715

Source DB:  PubMed          Journal:  Mol Biol Evol        ISSN: 0737-4038            Impact factor:   16.240


  23 in total

1.  Molecular basis of adaptive convergence in experimental populations of RNA viruses.

Authors:  José M Cuevas; Santiago F Elena; Andrés Moya
Journal:  Genetics       Date:  2002-10       Impact factor: 4.562

Review 2.  Molecular clocks and the puzzle of RNA virus origins.

Authors:  Edward C Holmes
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

3.  Effect of recombination on the accuracy of the likelihood method for detecting positive selection at amino acid sites.

Authors:  Maria Anisimova; Rasmus Nielsen; Ziheng Yang
Journal:  Genetics       Date:  2003-07       Impact factor: 4.562

Review 4.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

5.  Evidence of positive Darwinian selection in Omp85, a highly conserved bacterial outer membrane protein essential for cell viability.

Authors:  David A Fitzpatrick; James O McInerney
Journal:  J Mol Evol       Date:  2005-02       Impact factor: 2.395

6.  Molecular evolution of the hepatitis delta virus antigen gene: recombination or positive selection?

Authors:  Maria Anisimova; Ziheng Yang
Journal:  J Mol Evol       Date:  2004-12       Impact factor: 2.395

7.  Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range.

Authors:  Jaume Jorba; Ray Campagnoli; Lina De; Olen Kew
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

8.  Competition-colonization dynamics in an RNA virus.

Authors:  Samuel Ojosnegros; Niko Beerenwinkel; Tibor Antal; Martin A Nowak; Cristina Escarmís; Esteban Domingo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-13       Impact factor: 11.205

9.  Positive selection in the N-terminal extramembrane domain of lung surfactant protein C (SP-C) in marine mammals.

Authors:  Natalie J Foot; Sandra Orgeig; Stephen Donnellan; Terry Bertozzi; Christopher B Daniels
Journal:  J Mol Evol       Date:  2007-06-12       Impact factor: 2.395

10.  Evaluating the within-host fitness effects of mutations fixed during virus adaptation to different ecotypes of a new host.

Authors:  Julia Hillung; José M Cuevas; Santiago F Elena
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-08-19       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.